Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional
Official Title: A Study of Gemcitabine, L- Asparaginase, Ifosfamide, Dexamethasone and Etoposide Chemotherapy Followed by ASCT for Newly Diagnosed Stage IV, Relapsed or Refractory Extranodal Natural Killer/T-cell Lym
Brief Summary: This study is to explore the efficacy and safety of GLIDE regiment in patients with aggressive NK/T cell lymphoma.